Mutational landscape and clonal architecture in grade II and III gliomas

By Hiromichi Suzuki, Kosuke Aoki, K. Chiba, Yusuke Sato, Y. Shiozawa, Y. Shiraishi, Teppei Shimamura, A. Niida, K. Motomura, F. Ohka and 21 more. Nature Genetics, 2015

782 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/fd5725914afe30847af0152eaa17f7e9dd7756fe

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Tiago C. Silva
2. Matthew Meyerson
3. Peter W. Laird
4. David Haussler
5. M. Lawrence
6. Charles M. Perou
7. Kenneth D. Aldape
8. Jason T. Huse

In Genetics

1. Hui Shen
2. Jill S. Barnholtz-Sloan
3. Olena Morozova
4. P. Park
5. Peter W. Laird
6. David Haussler
7. Marco A. Marra
8. Steven J. M. Jones

In Modeling and Simulation

1. Wei Zhang

Citations in the corpus

• Glioma Subclassifications and Their Clinical Significance (2017, background): “Detailed sequencing of individual tumors and matched initial and recurrent tumors suggests that IDHmutation is a relatively early event (perhaps the initiating event) in these tumors [21].”
• Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma (2016, positive): “Details of data generation have been previously reported (Brennan et al., 2013; TCGA_Network et al., 2015).”